Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Insulin Resistance and NAMPT[original query] |
|---|
| Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population. Cytokine 2010 Jul 51 (1): 25-7. Paschou Peristera, Kukuvitis Asterios, Yavropoulou Maria P, Dritsoula Athina, Giapoutzidis Vasilios, Anastasiou Olympia, Kazakos Kyriakos, Yovos John |
| NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus. Clinical and experimental pharmacology & physiology 2011 Aug 38 (8): 550-4. Sheng Fei-Feng, Dai Xing-Ping, Qu Jian, Lei Guang-Hua, Lu Hong-Bin, Wu Jing, Xu Xiao-Jing, Pei Qi, Dong Min, Liu Ying-Zi, Zhou Hong-Hao, Liu Zhao-Qi |
| Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects. Cardiovascular diabetology 2013 12 (1): 119. Saddi-Rosa Pedro, Oliveira Carolina, Crispim Felipe, Giuffrida Fernando M A, de Lima Valter, Vieira José, Doria Alessandro, Velho Gilberto, Reis And |
| Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study. Virulence 2021 1 12 (1): 270-280. Chang Ming-Ling, Lin Yu-Sheng, Chang Ming-Yu, Hsu Chia-Lin, Chien Rong-Nan, Fann Cathy |
- Page last reviewed:Feb 1, 2024
- Content source: